BioSig技术公司与Streamex Exchange公司合并,组成一家Nasdaq上市公司,由Streamex公司首席执行官领导。 BioSig Technologies merges with Streamex Exchange to form a Nasdaq-listed company, with Streamex CEO leading.

BioSig Technologies是一家医疗技术公司,它签订了一份意向书,准备与Sreamex Exchange Corp.公司合并,该公司是一家真实世界资产象征性化公司,在全股交易中进行合并。 BioSig Technologies, a medical tech company, has entered into a Letter of Intent to merge with Streamex Exchange Corp., a real-world asset tokenization firm, in an all-stock deal. 合并的目的是在Nasdaq上建立一个上市公司,扩大市场范围和提高能力。 The merger aims to create a publicly listed company on the Nasdaq, expanding market reach and enhancing capabilities. Streamex公司的首席执行官Henry McPhie将领导联合实体,而 Streamex公司股东在转换后将拥有新公司75%的股票。 Streamex's CEO, Henry McPhie, will lead the combined entity, and Streamex stockholders are set to own up to 75% of the new company's stock after conversion.